Clinical Trial Update: Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates using spirometry to guide intravenous immunoglobulin (IgG) therapy in Common Variable Immunodeficiency with airway disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Common Variable Immunodeficiency | Phase 4 | Status: RECRUITING